By Rebecca Strong, Children's Health Defense - In 1973, my grandpa and his colleagues celebrated as Pfizer crossed a milestone: the one-billion-dollar sales mark. These days, Pfizer rakes in $81 billion a year, making it the 28th most valuable company in the world. Johnson & Johnson ranks 15th, with $93.77 billion... To put things into perspective, that makes said companies wealthier than most countries in the world. And thanks to those astronomical profit margins, the pharmaceuticals and health products industry is able to spend more on lobbying than any other industry in America.